Cuffless Blood Pressure as a Digital Biomarker

Cuffless blood pressure is the most commercially advanced and least scientifically settled measure in this library. This page states what the evidence supports today.

Status
Exploratory
Unit
mmHg (systolic/diastolic)
Data type
Composite
Sensor
Optical PPG with cuff calibration
Worn
Wrist

Evidence maturity

Graded with the V3 framework: whether the sensor measures accurately, whether the algorithm has been validated against a reference standard, and whether the measure has been shown to matter clinically.

Verification
Emerging
Analytical validation
Limited
Clinical validation
Limited

Professional societies in Europe and the United States have published statements and dedicated validation requirements, and independent evaluation has found poor tracking of induced pressure change in a commercial wearable. No cuffless wearable is established as a substitute for cuff measurement.

What is Cuffless Blood Pressure

Cuffless blood pressure means estimating arterial pressure without inflating a cuff, typically from features of the pulse waveform recorded optically at the wrist or finger. It is the measure in this library where the distance between what is sold and what is validated is largest, so this page is written primarily to mark that distance.

The physical problem is that no wearable sensor measures pressure. Cuffless devices measure a correlate, usually a timing or morphology feature of the pulse wave, and convert it to a pressure estimate using a model. That model is fitted to the individual during a calibration against a real cuff, and it drifts as vascular properties change with posture, temperature, medication, arousal and time since calibration.

Professional societies have been explicit about the consequences. Both European and American statements have set out that current validation protocols were designed for cuff devices and do not establish whether a cuffless device tracks real pressure change in an individual.

How it is measured

Most implementations derive pulse arrival or pulse transit time, the interval between a cardiac electrical event and the arrival of the pressure wave at a peripheral site, or extract morphological features from the photoplethysmogram alone. A regression or machine learning model maps those features to systolic and diastolic estimates.

Nearly all require initial calibration against a validated cuff, and recalibration at intervals. This is the crux of the accuracy debate: a device calibrated to a person's current pressure will appear accurate while their pressure stays near the calibration point, and the meaningful test is whether it tracks change away from it. Evaluations designed to test exactly that in a commercially available wearable have reported that tracking of induced blood pressure change was poor.

The European Society of Hypertension has published dedicated validation requirements for cuffless devices, which existing consumer implementations largely predate.

Clinical use

The clinical prize is real, which is why the field persists. Blood pressure is the leading modifiable cardiovascular risk factor, cuff measurement is intermittent and disliked, and nocturnal pressure and its variability carry prognostic information that clinic readings miss entirely.

In research today the defensible uses are narrow. Cuffless output can be collected as an exploratory signal alongside validated cuff measurement, and it can be studied as the object of research rather than used as a measurement instrument. It should not be used to titrate antihypertensive treatment, to diagnose hypertension, or as a trial endpoint.

The measure has no questionnaire counterpart, and unlike most entries in this library that is not a gap to be filled: blood pressure's reference standard is a validated cuff, which is why this page is about device to cuff agreement rather than about a patient reported construct.

Regulatory status

Regulatory status varies by market and by feature, and this library does not assert clearance for any cuffless product. Claims should be checked against the relevant regulator rather than against product marketing.

Limitations

Calibration dependence is the central limitation. Accuracy decays with time since calibration and is worst exactly where clinical interest is highest, at pressures far from the calibration point.

Regulatory status varies by market and by feature, and a function available in one country may be unavailable or differently labelled in another. Any claim that a given device is cleared should be checked against that market's regulator rather than against marketing copy, and this library does not assert clearance for any cuffless product.

Population level accuracy also masks individual error, and the groups most affected by hypertension are underrepresented in validation datasets. An estimate that is accurate on average across a cohort can be substantially wrong for the person in front of you, which is the only level at which blood pressure is acted on.

References

  • Stergiou GS, et al. European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices. J Hypertens. 2023. pubmed.ncbi.nlm.nih.gov
  • Mukkamala R, et al. Cuffless blood pressure measurement: where do we actually stand? Hypertension. 2025. pubmed.ncbi.nlm.nih.gov
  • Cohen JB, et al. Cuffless devices for the measurement of blood pressure: a scientific statement from the American Heart Association. Hypertension. 2026. pubmed.ncbi.nlm.nih.gov
  • Tan I, et al. Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes. J Hypertens. 2023. pubmed.ncbi.nlm.nih.gov
Related instruments

Blood pressure has no patient reported counterpart. Its reference standard is a validated cuff, not a questionnaire, which is why the evidence section on this page focuses on device to cuff agreement.

Use case
Monitoring
Run cardiovascular studies with WeGuide, the all in one patient engagement platform
Capture wearable physiology alongside validated measurements and patient reported outcomes in one workflow.

Collect your digital biomarker data in no time all under your own brand

Collect meaningful digital biomarker data from your patients with ease. Our platform connects with wearables, smartphones, and other digital health devices, helping you capture continuous, real world data for research or clinical use all within your own branded experience.

Learn More

Connect your Data Sources

Connect wearables, smartphones, and digital health devices to collect relevant biomarker data directly from your patients.
Learn More
We Guide

Collect Data Continuously

Capture passive and active digital biomarker data such as activity, sleep, heart rate, mobility, and other vital signals over time.
Learn More

Collect the Data that Matters

Collect the digital health data most relevant to your research or clinical program. Choose the measurements and data points that support your specific study objectives and use case.
Learn More

Monitor the Full Patient Journey

Collect longitudinal biomarker data throughout the patient journey, from onboarding and baseline assessment to ongoing monitoring and follow up.
Learn More
Build your own biomarker, gather
evidence and commerclise
support screenshot
Pallete Paints

Rapidly design and configure complex studies in one place.

Set up your study without the technical friction. Easily define and configure all the critical data points you need to collect from patient reported forms and clinical tests to remote wearables using our intuitive, centralised platform.
Clinical Trial Builder

Capture unified, multimodal data with automated workflows.

Utilise WeGuide Engage to build your required dataset effortlessly. Keep participants and clinicians actively involved through automated prompts, ensuring high compliance and consistent data capture across all modalities.
We Guide
We Guide
Toggle Right

Evaluate clinical algorithms instantly with AI powered tools.

Bypass the technical bottlenecks with our biomarker development studio. Seamlessly create, score, and evaluate complex algorithms with the click of a button, turning raw data into validated insights without bespoke coding.
We Guide

Distribute directly via our Class IIb certified platform.

Seamlessly transition from research to revenue. Commercialise your digital biomarker instantly on our regulatory approved infrastructure, making it immediately available for pharma, clinical trials, and real-world interventions.